Fixed-dose combination therapy for cardiovascular prevention
نویسندگان
چکیده
منابع مشابه
Fixed-dose combination therapy for the prevention of cardiovascular disease.
This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the effectiveness of fixed-dose combination therapy on optimising CVD risk factors and reducing CVD fatal and non-fatal events for both primary and secondary prevention of CVD. Details of CVD events and risk factors included are listed in the methods. We will also determine any adverse events...
متن کاملFixed-dose combination Therapy in Hypertension: Focus on Fixed-dose combination of Amlodipine and Valsartan (exforge®)
Hypertension is the leading cause of disability and cardiovascular mortality world-wide. Approximately one-third of the US adult population and over a billion people world-wide have hypertension. Despite increased awareness of hypertension and availability of many effective antihypertensive agents, only one third of patients achieve their target blood pressure (BP). All expert panels now recomm...
متن کاملPolypill (fixed-dose combination) in the prevention of cardiovascular disease: rationale and clinical data
Cardiovascular diseases (CVDs) continue to be major contributors of death and disability globally. Control of CVD risk factors has been shown to be effective in reducing morbidity and mortality both in primary and secondary prevention settings. Given the cumulative benefits of concurrently controlling multiple CVD risk factors (high blood pressure, dyslipidemia and platelet activity) in individ...
متن کاملTriple fixed-dose combination therapy: back to the past.
In this issue of Hypertension, Calhoun et al1 report on a large (n 2271), short (9 weeks of treatment after 4 weeks of washout and placebo), well-designed, properly controlled, international randomized trial of a triple combination of a diuretic (D; hydrochlorothiazide [HCTZ]), a dihydropyridine calcium channel blocker (DHPCCB; amlodipine [A]), and an angiotensin reception blocker (ARB; valsart...
متن کاملSpillover adherence effects of fixed-dose combination HIV therapy
The impact of fixed-dose combination (FDC) products on adherence to other, non-fixed regimen components has not been examined. We compared adherence to a third antiretroviral (ART) component among patients receiving a nucleoside reverse transcriptase inhibitor (NRTI) backbone consisting of the FDC Epzicom(®), GlaxoSmithKline Inc, Research Triangle Park, NC (abacavir sulfate 600 mg + lamivudine ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Korean Medical Association
سال: 2016
ISSN: 1975-8456,2093-5951
DOI: 10.5124/jkma.2016.59.11.883